01.02.2010 • News

Bayer MaterialScience Combines Chinese Businesses

Bayer MaterialScience said it has combined its four units under Bayer MaterialScience (China) to offer improved services and prepare for bigger growth in the Chinese market, the Shanghai Daily reported.

After the consolidation, the four units will have a total investment of RMB 2.1 billion in fixed assets in Shanghai by 2012, said the newspaper. The German company will also integrate production, marketing and sales, as well as research and development activities in China, and it will produce RMB 4 billion worth of products annually from the country which has become its third-largest market worldwide, and a growth engine for its global business.

Bayer's new manufacturing plant will be completed by the end of 2010 with an initial annual production capacity of 250,000 tons of toluene diisocyanate.

Special Issue

Circular Plastics Economy
Explore the Future of Plastics

Circular Plastics Economy

This special CHEManager issue explores the industry’s pivotal shift towards a more sustainable, circular plastics value chain. Readers will find expert analysis and real-world solutions for today’s most pressing recycling and regulatory challenges.

Expert Insights

ADCs for Precision Cancer Therapy
Comprehensive Insights into Antibody–Drug Conjugates

ADCs for Precision Cancer Therapy

Explore how antibody-drug conjugates are reshaping precision cancer therapy and discover what it takes to successfully develop, manufacture, and scale these complex biologics.

most read

Photo

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.